Base the short-term use of ibuprofen in infants aged 3–6 months on body weight and administer via the oral route if possible
- 113 Downloads
Ibuprofen is the NSAID most commonly used to treat mild-moderate pain, fever and inflammation in children, although dosage recommendations in infants aged 3–6 months still differ between countries. Based on the available evidence, the short-term use of ibuprofen to manage pain and fever appears to be effective and safe in infants aged 3–6 months who weigh ≥ 5–6 kg. The dosage should be weight-based, with preference given to oral preparations. To minimize the risk of renal toxicity, it is important to ensure than the infant is adequately hydrated.
Compliance with ethical standards
Conflict of interest
The article was adapted from Pediatric Drugs 2017;19(4):277–20  by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.
The preparation of this review was not supported by any external funding.
- 6.Vilenchik R, Berkovitch M, Jossifoff A, et al. Oral versus rectal ibuprofen in healthy volunteers. J Popul Ther Clin. 2012;19(2):e179–86.Google Scholar
- 18.Summary review for regulatory action. Caldolor injection/ibuprofen intravenous injection (NDA 22348, Supplement 005). Silver Spring: US Food and Drug Administration; 2015.Google Scholar